Lucy Cureton

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 391 citations · Full text

Long Covid, Treatment And Prevention, Covid-19 Pandemic +9

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial

Sally Hopewell, David J. Keene, Ioana R. Marian et al. · The Lancet · 2021 · 111 citations · Full text

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Timothy Hinks, Lucy Cureton, Ruth Knight et al. · The Lancet Respiratory Medicine · 2021 · 85 citations · Full text

Mild-to-moderate Covid-19, Antibiotics, Standard Care +8

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

Abhishek Abhishek, Rosemary J. Boyton, Nicholas Peckham et al. · The Lancet Respiratory Medicine · 2022 · 81 citations · Full text

Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT

Sally Hopewell, David J. Keene, Peter Heine et al. · Health Technology Assessment · 2021 · 50 citations · Full text